238 related articles for article (PubMed ID: 27743705)
1. Emerging role of mesenchymal stem cells during tuberculosis: The fifth element in cell mediated immunity.
Khan A; Hunter RL; Jagannath C
Tuberculosis (Edinb); 2016 Dec; 101S():S45-S52. PubMed ID: 27743705
[TBL] [Abstract][Full Text] [Related]
2. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.
Källenius G; Correia-Neves M; Buteme H; Hamasur B; Svenson SB
Tuberculosis (Edinb); 2016 Jan; 96():120-30. PubMed ID: 26586646
[TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
4. Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection.
Mohareer K; Asalla S; Banerjee S
Tuberculosis (Edinb); 2018 Dec; 113():99-121. PubMed ID: 30514519
[TBL] [Abstract][Full Text] [Related]
5. Macrophage defense mechanisms against intracellular bacteria.
Weiss G; Schaible UE
Immunol Rev; 2015 Mar; 264(1):182-203. PubMed ID: 25703560
[TBL] [Abstract][Full Text] [Related]
6. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases.
Shi Y; Wang Y; Li Q; Liu K; Hou J; Shao C; Wang Y
Nat Rev Nephrol; 2018 Aug; 14(8):493-507. PubMed ID: 29895977
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cells and the innate immune response.
Le Blanc K; Davies LC
Immunol Lett; 2015 Dec; 168(2):140-6. PubMed ID: 25982165
[TBL] [Abstract][Full Text] [Related]
8. Cellular therapy in tuberculosis.
Parida SK; Madansein R; Singh N; Padayatchi N; Master I; Naidu K; Zumla A; Maeurer M
Int J Infect Dis; 2015 Mar; 32():32-8. PubMed ID: 25809753
[TBL] [Abstract][Full Text] [Related]
9. The Role of microRNAs and Long Non-Coding RNAs in the Regulation of the Immune Response to
Kundu M; Basu J
Front Immunol; 2021; 12():687962. PubMed ID: 34248974
[TBL] [Abstract][Full Text] [Related]
10. Human mesenchymal stem cells: New sojourn of bacterial pathogens.
Kohli S; Singh Y; Sowpati DT; Ehtesham NZ; Dobrindt U; Hacker J; Hasnain SE
Int J Med Microbiol; 2015 May; 305(3):322-6. PubMed ID: 25648374
[TBL] [Abstract][Full Text] [Related]
11. An Interplay Between Autophagy and Immunometabolism for Host Defense Against Mycobacterial Infection.
Paik S; Jo EK
Front Immunol; 2020; 11():603951. PubMed ID: 33262773
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stromal Cell Therapy in MDR/XDR Tuberculosis: A Concise Review.
Joshi L; Chelluri LK; Gaddam S
Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):427-33. PubMed ID: 26100384
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases.
Devi A; Pahuja I; Singh SP; Verma A; Bhattacharya D; Bhaskar A; Dwivedi VP; Das G
Cell Mol Immunol; 2023 Jun; 20(6):600-612. PubMed ID: 37173422
[TBL] [Abstract][Full Text] [Related]
14. IRAK-M alters the polarity of macrophages to facilitate the survival of Mycobacterium tuberculosis.
Shen P; Li Q; Ma J; Tian M; Hong F; Zhai X; Li J; Huang H; Shi C
BMC Microbiol; 2017 Aug; 17(1):185. PubMed ID: 28835201
[TBL] [Abstract][Full Text] [Related]
15. Preclinical and Clinical Evidence of Mycobacterium tuberculosis Persistence in the Hypoxic Niche of Bone Marrow Mesenchymal Stem Cells after Therapy.
Garhyan J; Bhuyan S; Pulu I; Kalita D; Das B; Bhatnagar R
Am J Pathol; 2015 Jul; 185(7):1924-34. PubMed ID: 26066709
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice.
Dameshghi S; Zavaran-Hosseini A; Soudi S; Shirazi FJ; Nojehdehi S; Hashemi SM
Immunol Lett; 2016 Feb; 170():15-26. PubMed ID: 26703818
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities.
Zhang X; Xie Q; Ye Z; Li Y; Che Z; Huang M; Zeng J
Front Immunol; 2021; 12():695278. PubMed ID: 34367155
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells and infectious diseases: Smarter than drugs.
Mezey É; Nemeth K
Immunol Lett; 2015 Dec; 168(2):208-14. PubMed ID: 26051681
[TBL] [Abstract][Full Text] [Related]
19. A Novel Therapeutic Approach Using Mesenchymal Stem Cells to Protect Against Mycobacterium abscessus.
Kim JS; Cha SH; Kim WS; Han SJ; Cha SB; Kim HM; Kwon KW; Kim SJ; Choi HH; Lee J; Cho SN; Koh WJ; Park YM; Shin SJ
Stem Cells; 2016 Jul; 34(7):1957-70. PubMed ID: 26946350
[TBL] [Abstract][Full Text] [Related]
20. Latest Comprehensive Knowledge of the Crosstalk between TLR Signaling and Mycobacteria and the Antigens Driving the Process.
Kim JS; Kim YR; Yang CS
J Microbiol Biotechnol; 2019 Oct; 29(10):1506-1521. PubMed ID: 31581380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
